Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Role of Lys 558 and Lys 869 in substrate and inhibitor binding to the murine band 3 protein: a study of the effects of site-directed mutagenesis of the band 3 protein expressed in the oocytes of Xenopus laevis.
Wood PG
,
Müller H
,
Sovak M
,
Passow H
.
???displayArticle.abstract???
The effect of mutation of either Lys 558 or Lys 869 or both on mouse erythroid band 3 protein (AE1)-mediated 36Cl- efflux and its inhibition by pyridoxal 5-phosphate (P5-P), DNDS and H2DIDS were studied. Regardless of the mutation, band 3 was always capable of executing Cl- self-exchange. P5-P (5 mM, pH 7.6) produced irreversible inhibition in the wild type (KK) and in the mutant in which Lys 558 (NK) or Lys 869 (KM) had been replaced by asparagine (N) or methionine (M), respectively. However, when both residues were replaced, mutant (NM), irreversible inhibition could no longer be achieved. This shows that P5-P is capable of producing inhibition with either one of the lysine residues, 558 or 869. Inhibition by DNDS changed dramatically upon mutation. The Ki app increased from 6.0 microM in the wild type (KK) to 23 microM in the mutant NK, to 73 microM in the mutant KM and to 474 microM in the double mutant NM. The Km value for activation of the transport system by varying the substrate concentration by isosmotic substitution of Cl- with SO4(2-) decreased from 42 mM in the wild type (KK) to 11.3 mM in the mutant NM. The results show that both Lys 558 and Lys 869 are involved in the maintenance of the structure of the overlapping binding sites for stilbene disulfonates and the substrate Cl-. In the double mutant NM, H2DIDS is no longer able to produce irreversible inhibition at pH 7.6. This is evidently related to the replacement of Lys 558 (pK 8.2) by Asn 558 in this mutant (see Bartel, D., Lepke, S., Layh-Schmitt, G., Legrum, B., Passow, H., 1989. EMBO J. 8:3601-3609). However, at pH 9.5, some irreversible inhibition could still be observed. This suggests that the other lysine residue (pK 10.8) that is known to be involved in covalent binding with the second isothiocyanate group of H2DIDS is still present, and hence, not identical to Lys 869, which had been substituted by a methionine residue. However, this result remains inconclusive since after mutagenesis, the H2DIDS may produce inhibition at a site that is not normally involved in H2DIDS binding.
Bar-Noy,
Transport domain of the erythrocyte anion exchange protein.
1990, Pubmed
Bar-Noy,
Transport domain of the erythrocyte anion exchange protein.
1990,
Pubmed
Bartel,
Identification by site-directed mutagenesis of Lys-558 as the covalent attachment site of H2DIDS in the mouse erythroid band 3 protein.
1989,
Pubmed
,
Xenbase
Bartel,
Anion transport in oocytes of Xenopus laevis induced by expression of mouse erythroid band 3 protein--encoding cRNA and of a cRNA derivative obtained by site-directed mutagenesis at the stilbene disulfonate binding site.
1989,
Pubmed
,
Xenbase
Barzilay,
Anion transport in red blood cells. II. Kinetics of reversible inhibition by nitroaromatic sulfonic acids.
1979,
Pubmed
Cabantchik,
Pyridoxal phosphate. An anionic probe for protein amino groups exposed on the outer and inner surfaces of intact human red blood cells.
1975,
Pubmed
Cabantchik,
Membrane proteins related to anion permeability of human red blood cells. I. Localization of disulfonic stilbene binding sites in proteins involved in permeation.
1974,
Pubmed
Cobb,
Identification of the eosinyl-5-maleimide reaction site on the human erythrocyte anion-exchange protein: overlap with the reaction sites of other chemical probes.
1990,
Pubmed
Cousin,
Inhibition of anion permeability by amphiphilic compounds in human red cell: evidence for an interaction of niflumic acid with the band 3 protein.
1979,
Pubmed
Cousin,
Inhibition of anion transport in the red blood cell by anionic amphiphilic compounds. I. Determination of the flufenamate-binding site by proteolytic dissection of the band 3 protein.
1982,
Pubmed
Cousin,
Inhibition of anion transport in the red blood cell by anionic amphiphilic compounds. II. Chemical properties of the flufenamate-binding site on the band 3 protein.
1982,
Pubmed
Falke,
Chloride binding to the anion transport binding sites of band 3. A 35Cl NMR study.
1984,
Pubmed
Fröhlich,
The external anion binding site of the human erythrocyte anion transporter: DNDS binding and competition with chloride.
1982,
Pubmed
Glibowicka,
Temperature dependence of anion transport in the human red blood cell.
1988,
Pubmed
Grygorczyk,
Measurement of erythroid band 3 protein-mediated anion transport in mRNA-injected oocytes of Xenopus laevis.
1989,
Pubmed
,
Xenbase
Jennings,
Anion transport across the erythrocyte membrane, in situ proteolysis of band 3 protein, and cross-linking of proteolytic fragments by 4,4'-diisothiocyano dihydrostilbene-2,2'-disulfonate.
1979,
Pubmed
Jennings,
Structure and function of the red blood cell anion transport protein.
1989,
Pubmed
Kampmann,
The kinetics of intramolecular cross-linking of the band 3 protein in the red blood cell membrane by 4,4'-diisothiocyano dihydrostilbene-2,2'-disulfonic acid (H2DIDS).
1982,
Pubmed
Kawano,
Localization of the pyridoxal phosphate binding site at the COOH-terminal region of erythrocyte band 3 protein.
1988,
Pubmed
Kawano,
Isolation of a 5,300-dalton peptide containing a pyridoxal phosphate binding site from the 38,000-dalton domain of band 3 of human erythrocyte membranes.
1986,
Pubmed
Kietz,
pH-dependence of inhibition by H2DIDS of mouse erythroid band 3-mediated Cl- transport in Xenopus oocytes. The effect of oligonucleotide-directed replacement of Lys-558 by an Asn residue.
1991,
Pubmed
,
Xenbase
Kramer,
Oligonucleotide-directed construction of mutations via gapped duplex DNA.
1987,
Pubmed
Lepke,
Effects of incorporated trypsin on anion exchange and membrane proteins in human red blood cell ghosts.
1976,
Pubmed
Passow,
Anion transport across the red blood cell membrane and the conformation of the protein in Band 3.
1980,
Pubmed
Passow,
Molecular aspects of band 3 protein-mediated anion transport across the red blood cell membrane.
1986,
Pubmed
Salhany,
Characterization of pyridoxal 5'-phosphate affinity labeling of band 3 protein. Evidence for allosterically interacting transport inhibitory subdomains.
1987,
Pubmed
Sanger,
DNA sequencing with chain-terminating inhibitors.
1977,
Pubmed
Shami,
Inhibition of C1- binding to anion transport protein of the red blood cell by DIDS (4, 4'-diisothiocyano-2, 2'-stilbene disulfonic acid) measured by [35C1]NMR.
1976,
Pubmed
Shami,
Identification of the Cl- transport site of human red blood cells by a kinetic analysis of the inhibitory effects of a chemical probe.
1978,
Pubmed